{"id":"https://openalex.org/W4400448379","doi":"https://doi.org/10.3390/ph17070916","title":"Where Are We Now with Oncolytic Viruses in Melanoma and Nonmelanoma Skin Malignancies?","display_name":"Where Are We Now with Oncolytic Viruses in Melanoma and Nonmelanoma Skin Malignancies?","publication_year":2024,"publication_date":"2024-07-09","ids":{"openalex":"https://openalex.org/W4400448379","doi":"https://doi.org/10.3390/ph17070916","pmid":"https://pubmed.ncbi.nlm.nih.gov/39065766","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11279659"},"language":"en","primary_location":{"id":"doi:10.3390/ph17070916","doi":"https://doi.org/10.3390/ph17070916","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph17070916","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/ph17070916","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093908438","display_name":"George Nassief","orcid":"https://orcid.org/0009-0000-4271-7868","observed_orcids":["https://orcid.org/0009-0000-4271-7868"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Nassief","raw_affiliation_strings":["Division of Medical Oncology, Department of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA"],"raw_orcid":"https://orcid.org/0009-0000-4271-7868","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023740134","display_name":"Angela Anaeme","orcid":"https://orcid.org/0000-0002-8921-3744","observed_orcids":["https://orcid.org/0000-0002-8921-3744"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Anaeme","raw_affiliation_strings":["Division of Medical Oncology, Department of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111974863","display_name":"Karen Moussa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75421653","display_name":"University of Missouri\u2013Kansas City","ror":"https://ror.org/01w0d5g70","country_code":"US","type":"education","lineage":["https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Moussa","raw_affiliation_strings":["UMKC School of Medicine, University of Missouri Kansas City, Kansas City, MO 64108, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UMKC School of Medicine, University of Missouri Kansas City, Kansas City, MO 64108, USA","institution_ids":["https://openalex.org/I75421653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002111756","display_name":"David Y. Chen","orcid":"https://orcid.org/0000-0002-3681-6576","observed_orcids":["https://orcid.org/0000-0002-3681-6576","https://orcid.org/0009-0007-5537-9096"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Chen","raw_affiliation_strings":["Division of Dermatology, Department of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Dermatology, Department of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080536692","display_name":"George Ansstas","orcid":"https://orcid.org/0000-0002-7178-8777","observed_orcids":["https://orcid.org/0000-0002-7178-8777"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"George Ansstas","raw_affiliation_strings":["Division of Medical Oncology, Department of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA"],"raw_orcid":"https://orcid.org/0000-0002-7178-8777","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Department of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA","institution_ids":["https://openalex.org/I204465549"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5080536692"],"corresponding_institution_ids":["https://openalex.org/I204465549"],"apc_list":{"value":2900,"currency":"CHF","value_usd":3296},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3296},"fwci":0.6712,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.54318707,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"17","issue":"7","first_page":"916","last_page":"916"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.8134999871253967,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.8134999871253967,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0892999991774559,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.02280000038444996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-viruses","display_name":"oncolytic viruses","score":0.9929999709129333},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8619999885559082},{"id":"https://openalex.org/keywords/non-melanoma-skin-cancer","display_name":"non-melanoma skin cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/talimogene-laherparepvec","display_name":"talimogene laherparepvec","score":0.9900000095367432},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.8330000042915344},{"id":"https://openalex.org/keywords/pembrolizumab-combination","display_name":"pembrolizumab combination","score":0.8389999866485596},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.6460000276565552},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9010440111160278},{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.8375284671783447},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6301860809326172},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5959229469299316},{"id":"https://openalex.org/C2777789703","wikidata":"https://www.wikidata.org/wiki/Q192102","display_name":"Skin cancer","level":3,"score":0.5862681865692139},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.5814314484596252},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5220641493797302},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5073944926261902},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4713439643383026},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4565463066101074},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3832142949104309},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.21032989025115967}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3390/ph17070916","doi":"https://doi.org/10.3390/ph17070916","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph17070916","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11279659","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11279659","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11279659/pdf/pharmaceuticals-17-00916.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals (Basel)","raw_type":"Text"},{"id":"pmid:39065766","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39065766","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals (Basel, Switzerland)","raw_type":"Journal Article"},{"id":"pmh:oai:digitalcommons.wustl.edu:oa_4-4954","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.wustl.edu/oa_4/3965","pdf_url":null,"source":{"id":"https://openalex.org/S4306400764","display_name":"Digital Commons@Becker (Washington University School of Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I204465549","host_organization_name":"Washington University in St. Louis","host_organization_lineage":["https://openalex.org/I204465549"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"2020-Current year OA Pubs","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:f0c599bb67e642859e071d3c5e64c282","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/f0c599bb67e642859e071d3c5e64c282","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceuticals, Vol 17, Iss 7, p 916 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/ph17070916","doi":"https://doi.org/10.3390/ph17070916","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph17070916","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400448379.pdf","grobid_xml":"https://content.openalex.org/works/W4400448379.grobid-xml"},"referenced_works_count":60,"referenced_works":["https://openalex.org/W1971941564","https://openalex.org/W2040600853","https://openalex.org/W2042793636","https://openalex.org/W2099648846","https://openalex.org/W2134391698","https://openalex.org/W2215070146","https://openalex.org/W2305610317","https://openalex.org/W2400930181","https://openalex.org/W2736194991","https://openalex.org/W2769590270","https://openalex.org/W2801067660","https://openalex.org/W2808686638","https://openalex.org/W2889911665","https://openalex.org/W2898003394","https://openalex.org/W2898830231","https://openalex.org/W2904269909","https://openalex.org/W2912374321","https://openalex.org/W2914345456","https://openalex.org/W2948662515","https://openalex.org/W2967139876","https://openalex.org/W2978554061","https://openalex.org/W3012656619","https://openalex.org/W3099844868","https://openalex.org/W3107446921","https://openalex.org/W3107738233","https://openalex.org/W3113696437","https://openalex.org/W3122662118","https://openalex.org/W3130683366","https://openalex.org/W3144959724","https://openalex.org/W3169399702","https://openalex.org/W3201686202","https://openalex.org/W3203855951","https://openalex.org/W4210483598","https://openalex.org/W4221034077","https://openalex.org/W4281649129","https://openalex.org/W4281657020","https://openalex.org/W4281765290","https://openalex.org/W4281888560","https://openalex.org/W4282022545","https://openalex.org/W4286295684","https://openalex.org/W4286866204","https://openalex.org/W4292851027","https://openalex.org/W4296009065","https://openalex.org/W4296071832","https://openalex.org/W4361190213","https://openalex.org/W4376112757","https://openalex.org/W4379162563","https://openalex.org/W4379281040","https://openalex.org/W4379281143","https://openalex.org/W4379282897","https://openalex.org/W4379283024","https://openalex.org/W4379283511","https://openalex.org/W4379345918","https://openalex.org/W4385716123","https://openalex.org/W4388084089","https://openalex.org/W4389480943","https://openalex.org/W4393167349","https://openalex.org/W4393987484","https://openalex.org/W4393988977","https://openalex.org/W6858439255"],"related_works":["https://openalex.org/W4281649129","https://openalex.org/W4318705700","https://openalex.org/W4409663461","https://openalex.org/W2888144531","https://openalex.org/W3047796464","https://openalex.org/W3213124514","https://openalex.org/W3015121259","https://openalex.org/W2900164408","https://openalex.org/W2561037714","https://openalex.org/W2806545858"],"abstract_inverted_index":{"Skin":[0],"cancer":[1,22,160],"prognosis":[2],"has":[3,46,165],"greatly":[4],"improved":[5],"recently":[6],"due":[7],"to":[8,128,168,193,228],"the":[9,99,102,109,121,141,150,170,197,218],"introduction":[10],"of":[11,111,144,172,188,201],"immune":[12],"checkpoint":[13],"inhibitors":[14],"(ICIs).":[15],"However,":[16,120],"many":[17],"patients":[18,58,137,233],"with":[19,59,92,138,209,234],"advanced":[20,118],"skin":[21,60,213,235],"still":[23],"experience":[24],"immunotherapy":[25],"resistance":[26],"and":[27,104,146,162,180,199,224],"disease":[28],"progression":[29],"during":[30],"ICI":[31,93],"treatment,":[32],"thus":[33],"calling":[34],"for":[35,57,232],"novel":[36],"therapeutics":[37],"which":[38,85],"address":[39],"this":[40],"treatment":[41,55],"gap.":[42],"Talimogene":[43],"laherparepvec":[44],"(T-VEC)":[45],"gained":[47],"popularity":[48],"in":[49,72,82,117,136,159,174,207,212,221],"recent":[50],"years":[51],"as":[52,75,77,113,178,203],"a":[53,68,78,114,186,204],"viable":[54],"option":[56],"cancer.":[61],"In":[62],"preclinical":[63],"studies,":[64],"T-VEC":[65,112,127,145],"demonstrated":[66,124],"both":[67],"direct":[69],"anti-tumor":[70],"effect":[71,81],"injected":[73],"lesions":[74],"well":[76],"systemic":[79],"immune-mediated":[80],"non-injected":[83],"lesions,":[84],"could":[86],"pose":[87],"additional":[88,133],"benefits":[89],"when":[90],"combined":[91],"therapy.":[94],"Following":[95],"promising":[96,142],"results":[97,190],"from":[98,191],"OPTiM":[100],"trial,":[101],"Food":[103],"Drug":[105],"Administration":[106],"(FDA)":[107],"approved":[108],"usage":[110,171],"single":[115],"agent":[116],"melanoma.":[119,139],"MASTERKEY-265":[122],"trial":[123],"that":[125,195],"adding":[126],"pembrolizumab":[129],"did":[130],"not":[131],"offer":[132],"clinical":[134,189,230],"benefit":[135],"Nevertheless,":[140],"efficacy":[143,198],"its":[147],"approval":[148],"by":[149],"FDA":[151],"helped":[152],"oncolytic":[153],"viruses":[154],"(OVs)":[155],"gain":[156],"wide":[157],"attention":[158],"therapy,":[161],"extensive":[163],"research":[164],"been":[166],"undertaken":[167],"evaluate":[169],"OVs":[173,202],"other":[175,210],"tumors":[176],"such":[177],"sarcomas":[179],"breast":[181],"cancers.":[182],"Here,":[183],"we":[184,216],"provide":[185],"review":[187],"2022":[192],"2024":[194],"investigate":[196],"safety":[200],"monotherapy":[205],"or":[206],"combination":[208],"therapies":[211],"malignancies.":[214],"Furthermore,":[215],"delineate":[217],"current":[219],"limitations":[220],"OV":[222],"utilization":[223],"outline":[225],"future":[226],"directions":[227],"enhance":[229],"outcomes":[231],"malignancies":[236],"receiving":[237],"OV-based":[238],"therapies.":[239]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-07-10T00:00:00"}
